Opening stock page...
Fetching company snapshot, pricing, and intelligence.
OKYO has basic price and filing data (45% intelligence coverage), but earnings analysis, financial metrics, and proprietary signals are still building. Explore a peer with deeper coverage below.
Intelligence coverage: 45%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 50% · prior close shown (market closed)
Limited proprietary earnings coverage for OKYO yet — signals will sharpen as filings and earnings are ingested.
Pipeline evidence · 79d ago
OKYO's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on OKYO.
Free accounts see more of this; Premium sees all of it.
Updated
What happened recently for OKYO Pharma Ltd (OKYO) — events, not interpretation.
Research & analysis only — not investment advice.
AlphaOS industries
Investment snapshot
OKYO's AI investment thesis
Upgrade to Premium for OKYO's full multi-agent investment thesis.
Free accounts see more of this; Premium sees all of it.
Unified data coverage and cross-signal highlights — market, SEC, earnings, opportunity
Strengthen intelligence
Prior close
$1.33
Market cap
$69.80M
Profitable
—
Net income
—
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for OKYO Pharma Ltd — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Follow OKYO Pharma Ltd through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
Connected companies and research pages from the AlphaOS knowledge graph.